Skip to content
  • Tuesday, 27 October 2026
  • 9:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare
Laboratory Automation & Robotics

Eli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare

Lana Keisha Jul 24, 2026 0

Indianapolis, IN – Pharmaceutical giant Eli Lilly has announced a definitive agreement to acquire AtaiBeckley, a clinical-stage biotechnology company focused…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha May 4, 2026 0

Eli Lilly, a pharmaceutical giant that just last year occupied the ninth position, has ascended to the pinnacle of the…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Apr 22, 2026 0

Eli Lilly has ascended to the pinnacle of the pharmaceutical industry, claiming the top spot in the prestigious Pharma 50…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Apr 15, 2026 0

The pharmaceutical industry, known for its dynamic shifts and competitive landscape, has witnessed a seismic change at its pinnacle. Eli…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Apr 7, 2026 0

Eli Lilly has ascended to the pinnacle of the pharmaceutical industry, claiming the top spot on the prestigious Pharma 50…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Mar 31, 2026 0

Eli Lilly has made a historic leap, claiming the top position in the prestigious Pharma 50 ranking for 2026, a…

Read More
Science News: A Century of Empowering Public Understanding of ScienceAI-Generated "Ghosts" Offer Digital Solace, Sparking Ethical DebatesVast Clouds of Interstellar Water Ice Found in Galactic NurseriesJapanese Researchers Identify Key Protein Interaction Regulating Sperm Development and Male Fertility
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ